Esophageal high-grade intraepithelial neoplasia
Showing 1 - 25 of >10,000
First-void Urine Samples for Follow-up of Women Treated for
Active, not recruiting
- Cervical Cancer
- Colli-Pee
- Qvintip
-
Wilrijk, Antwerp, BelgiumUniversity of Antwerp - Centre for the Evaluation of Vaccination
Nov 3, 2022
Vulvar Dysplasia, HPV-Related Vulvar Intraepithelial Neoplasia, Preinvasive Vulvar Disease Trial in Baltimore, Cleveland,
Active, not recruiting
- Vulvar Dysplasia
- +4 more
- artesunate ointment 40%
-
Baltimore, Maryland
- +3 more
Oct 31, 2022
Vulvar Diseases, HPV Infection, Vulvar HSIL Trial in Cleveland, Mayfield Heights (Artesunate ointment, Placebo ointment)
Not yet recruiting
- Vulvar Diseases
- +12 more
- Artesunate ointment
- Placebo ointment
-
Cleveland, Ohio
- +2 more
Oct 4, 2023
Cervical Intraepithelial Neoplasia Grade 2/3, Cervical Lesion Trial in Hangzhou (TCT test, Vaginoscopy, High throughput HPV
Recruiting
- Cervical Intraepithelial Neoplasia Grade 2/3
- Cervical Lesion
- TCT test
- +3 more
-
Hangzhou, Zhejiang, ChinaWomen's hospital school of medicine zhejiang university
May 5, 2023
AIDS-Related Anal Carcinoma, AIDS-Related Cervical Carcinoma, High Grade Anal Intraepithelial Neoplasia Trial in San Francisco,
Recruiting
- AIDS-Related Anal Carcinoma
- +4 more
- Biopsy
- +5 more
-
San Francisco, California
- +2 more
Jan 24, 2023
Vulvar Intraepithelial Neoplasia Grade 2, Vulvar Intraepithelial Neoplasia Grade 3 Trial (VTD-101 ointment)
Not yet recruiting
- Vulvar Intraepithelial Neoplasia Grade 2
- Vulvar Intraepithelial Neoplasia Grade 3
- VTD-101 ointment
- (no location specified)
Feb 3, 2023
Cervical Intraepithelial Neoplasia, Cervical Dysplasia Trial in New Haven (9-valent HPV vaccine, Imiquimod)
Active, not recruiting
- Cervical Intraepithelial Neoplasia
- Cervical Dysplasia
- 9-valent HPV vaccine
- Imiquimod
-
New Haven, ConnecticutSmilow Cancer Hospital at Yale New Haven
Aug 5, 2022
CIN3, Cervical Intraepithelial Neoplasia, Cervical Intraepithelial Neoplasia Grade 3 Trial in Groningen (Vvax001 therapeutic
Recruiting
- CIN3
- +3 more
- Vvax001 therapeutic cancer vaccine
-
Groningen, NetherlandsUniversity Medical Center Groningen (UMCG)
Aug 23, 2023
High-Grade Anal Intraepithelial Neoplasia Trial in Madison (Lopinavir / Ritonavir)
Not yet recruiting
- High-Grade Anal Intraepithelial Neoplasia
- Lopinavir / Ritonavir
-
Madison, WisconsinUW Digestive Health Center Anoscopy Clinic
Jan 12, 2023
Cervical Intraepithelial Neoplasia Grade 2/3, Cervical Squamous Cell Carcinoma In Situ, Cervical Squamous Intraepithelial
Active, not recruiting
- Cervical Intraepithelial Neoplasia Grade 2/3
- +3 more
- Imiquimod
- Topical Fluorouracil
-
Chapel Hill, North CarolinaUNC Lineberger Comprehensive Cancer Center
Jan 28, 2022
Vulvar Intraepithelial Neoplasia, Vulvar High Grade Squamous Intraepithelial Lesion, Differentiated Vulvar Intraepithelial
Recruiting
- Vulvar Intraepithelial Neoplasia
- +2 more
- Metvixia Topical Cream
-
Vandœuvre-lès-Nancy, FranceInstitut de Cancerologie de Lorraine
Dec 3, 2021
COrSIcA: Disease Measurement
Not yet recruiting
- Anal Intraepithelial Neoplasia
- +2 more
- Physical examination
- (no location specified)
May 4, 2023
Esophageal Squamous Cell Neoplasia (ESCN) Trial in Beijing (Radiofrequency ablation)
Terminated
- Esophageal Squamous Cell Neoplasia (ESCN)
- Radiofrequency ablation
-
Beijing, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Jul 29, 2020
Cervical Squamous Cell Carcinoma In Situ, Vulvar High Grade Squamous Intraepithelial Lesion Trial in Los Angeles, Oklahoma City
Recruiting
- Cervical Squamous Cell Carcinoma In Situ
- Vulvar High Grade Squamous Intraepithelial Lesion
- Cyclophosphamide
- +7 more
-
Los Angeles, California
- +1 more
Aug 19, 2022
Carcinoma, Neoplasia; Intraepithelial, Cervix, Glandular Tumors Trial in Havana (Glizigen® + Ocoxin-Viusid®)
Recruiting
- Carcinoma
- +4 more
- Glizigen® + Ocoxin-Viusid®
-
Havana, CubaOur Lady of Rule No. 52 &/Remedios and Quiroga, Luyano
Jul 5, 2022
Papilloma Viral Infection, CIN1, LSIL, Low Grade Squamous Intraepithelial Lesion Trial in Madrid (Glizigen, Placebo)
Recruiting
- Papilloma Viral Infection
- +2 more
- Glizigen
- Placebo
-
Madrid, Spain
- +3 more
Jun 27, 2023
Intra-epithelial Histological Lesions of High Grade Cervical
Recruiting
- HPV Infection
- Cervical Cancer
- abstention from CIN2 treatment and surveillance for at least 2 years
-
Bordeaux, FranceCHU Bordeaux
Apr 11, 2022
Cervical Intraepithelial Neoplasia Grade 2, DNA Methylation Trial in Maribor (Testing DNA methylation test for predicting
Recruiting
- Cervical Intraepithelial Neoplasia Grade 2
- DNA Methylation
- Testing DNA methylation test for predicting prognosis of untreated CIN 2
-
Maribor, SloveniaUniversity Medical Centre Maribor
Nov 14, 2022
Gastric Low Grade Intraepithelial Neoplasia Trial in Hong Kong (Hybrid Argon Plasma Coagulation)
Recruiting
- Gastric Low Grade Intraepithelial Neoplasia
- Hybrid Argon Plasma Coagulation
-
Hong Kong, Hong KongCombined Endoscopy Center, Prince of Wales Hospital
May 1, 2022
High Grade Anal Canal Intraepithelial Neoplasia, High Grade Vulvar Squamous Intraepithelial Lesion Trial in Birmingham, Seattle
Terminated
- High Grade Anal Canal Intraepithelial Neoplasia
- High Grade Vulvar Squamous Intraepithelial Lesion
- Laboratory Biomarker Analysis
- +3 more
-
Birmingham, Alabama
- +1 more
Jan 24, 2023
Cervical High Grade Squamous Intraepithelial Lesion, Cervical Intraepithelial Neoplasia Grade 2/3, CIN 2/3 Trial in Netherlands
Recruiting
- Cervical High Grade Squamous Intraepithelial Lesion
- +3 more
- Imiquimod
- +3 more
-
Breda, Netherlands
- +12 more
Jun 21, 2022
Cervical Intraepithelial Neoplasia Trial in Little Rock (PepCan, Candin®)
Active, not recruiting
- Cervical Intraepithelial Neoplasia
- PepCan
- Candin®
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
May 17, 2022
Primary Cervical Cancer Screening by Self-sampling HPV Test
Recruiting
- Human Papillomavirus Infection
- +16 more
-
Beijing, Beijing, China
- +5 more
Jan 12, 2023
Anal High Grade Squamous Intraepithelial Lesion, Anal Precancerous Condition, AIN 2/3 Trial in San Francisco, Chicago, New York
Not yet recruiting
- Anal High Grade Squamous Intraepithelial Lesion
- +5 more
- Artesunate
- Placebo
-
San Francisco, California
- +2 more
Nov 7, 2022
Cervical Intraepithelial Neoplasia Grade 1, Cervical Intraepithelial Neoplasia Grade 2 Trial in Linz (Trichloroacetic acid 85%
Completed
- Cervical Intraepithelial Neoplasia Grade 1
- Cervical Intraepithelial Neoplasia Grade 2
- Trichloroacetic acid 85% (TCA)
-
Linz, AustriaDepartment of gynaecology, Ordensklinikum Linz Ges.m.b.H, Barmhe
Mar 29, 2022